文献速递免疫规划

芬兰军事应征入伍者接种百日咳加强疫苗后年轻人百日咳发病率下降:1995-2015年芬兰百日咳流行病学分析

Decreased incidence of pertussis in young adults after the introduction of booster vaccine in military conscripts: Epidemiological analyses of pertussis in Finland, 1995-2015.
PubMed 文献 · Vaccine · 2017-08-18

芬兰2005年将全细胞百日咳疫苗改为无细胞疫苗,2012年7月起对应征入伍者提供百日咳加强剂。该研究分析1995-2015年国家传染病登记数据,发现19-21岁人群发病率从2011年49/10万降至2015年0.51/10万,男女均显著下降,作者认为支持对应征者实施加强剂。

要点

  • 2012年7月起芬兰对应征入伍者提供百日咳加强剂,入伍男性>95%为19-21岁。
  • 19-21岁普通人群发病率从2011年49/10万降至2015年0.51/10万(IRR=0.01;95%CI,0.00-0.16)。
  • 2012年7月前后3.5年比较,男性发病率从33/10万降至5.3/10万(IRR=0.16;95%CI,0.06-0.40),女性从16/10万降至5.0/10万(IRR=0.31;95%CI,0.11-0.84)。

核心结论

  • 芬兰军事应征入伍者实施百日咳加强剂后,19-21岁男女百日咳发病率均显著下降,可能反映群体免疫效应。
  • 结合青少年加强剂,已使包括婴儿在内的全人群发病率降低。
  • 作者认为结果支持对应征者实施加强剂,并建议继续监测百日咳流行病学以优化芬兰百日咳疫苗接种策略。

研究设计与样本

  • 基于国家传染病登记处实验室确诊百日咳通报病例的流行病学分析,使用人口数据计算年发病率,并用泊松回归计算发病率比(IRR)。

主要发现

  • 总体百日咳发病率2004年达峰(31/10万),2015年最低(3.0/10万);<3月龄婴儿报告病例2004年66例 vs 2015年6例。
  • 病例以女性为主(59%),男女病例比为1:1.5;全年均有病例,8月至次年2月发病率最高。
  • 19-21岁普通人群发病率从2011年49/10万降至2015年0.51/10万(IRR=0.01;95%CI,0.00-0.16)。
  • 2012年7月前后3.5年比较,同年龄组男性发病率从33/10万降至5.3/10万(IRR=0.16;95%CI,0.06-0.40),女性从16/10万降至5.0/10万(IRR=0.31;95%CI,0.11-0.84)。

临床怎么用

  • 作者认为结果支持对应征入伍者实施百日咳加强剂。
  • 作者建议继续监测百日咳流行病学以优化芬兰百日咳疫苗接种策略。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: In 2005, in Finland, the whole-cell pertussis vaccine was replaced by acellular given at 3-5-12months, and boosters at 4 and 11-15years of age. From July 2012, military conscripts have been offered a pertussis booster dose. Conscription is mandatory for Finnish men, and >95% were 19-21years old when enrolled during 2012-2015. We describe the epidemiology of pertussis in Finland during 1995-2015, and show the indirect effect of the booster in conscripts on pertussis incidence in the Finnish population. MATERIALS AND METHODS: We extracted data on laboratory confirmed notified pertussis cases from the National Infectious Diseases Register. We calculated annual incidence using as denominator population data and incidence rate ratios (IRR) using Poisson regression. RESULTS: The overall pertussis incidence peaked in 2004 (31/100,000) and was lowest in 2015 (3.0/100,000), with 66 reported cases in <3months infants in 2004 versus 6 in 2015. The majority of the cases were female (59%) with a male-to-female case ratio of 1:1.5. Cases were spread throughout the year with highest incidence during August-February. Among the 19- to 21-year-olds in the general population, incidence decreased from 49/100,000 in 2011 to 0.51/100,000 in 2015 (IRR=0.01; 95%CI, 0.00-0.16). Among the same age group, comparing the 3.5-year period before and after July 2012, incidence decreased from 33/100,000 to 5.3/100,000 (IRR=0.16; 95%CI, 0.06-0.40) in males and from 16/100,000 to 5.0/100,000 (IRR=0.31; 95%CI, 0.11-0.84) in females. CONCLUSIONS: Implementation of the pertussis booster dose in Finnish military conscripts was followed by a significant decrease in pertussis incidence both among the 19- to 21-year-old males and females, possibly reflecting herd immunity effect. Together with booster doses in adolescents this has resulted in low incidence in the whole population including infants. Our results support the implementation of the booster dose for conscripts. We recommend continuing monitoring pertussis epidemiology to optimize pertussis vaccination strategies in Finland.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Zöldi V, Sane J, Nohynek H, et al. Decreased incidence of pertussis in young adults after the introduction of booster vaccine in military conscripts: Epidemiological analyses of pertussis in Finland, 1995-2015. Vaccine. 2017. PMID: 28823620. doi:10.1016/j.vaccine.2017.08.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。